全国首批102名中医药传承博士后出站

2017-12-22 赵维婷 中国中医

经过4年临床跟师,我国首批102名中医药传承博士后正式出站。“传承博士后制度就是要解决高层次人才这头薄的问题。”12月16日,中国工程院院士、中国中医科学院院长张伯礼在全国中医药学术思想传承与博士后研究高峰论坛上表示。

经过4年临床跟师,我国首批102名中医药传承博士后正式出站。“传承博士后制度就是要解决高层次人才这头薄的问题。”12月16日,中国工程院院士、中国中医科学院院长张伯礼在全国中医药学术思想传承与博士后研究高峰论坛上表示。

张伯礼认为,中医药人才队伍层次及结构有待进一步优化,现在存在“两头薄中间弱”的问题。“两头薄”指高层次领军人才短缺,掌握中医辨证论治思维和能力的全科医生人数太少。“中间弱”指虽然队伍人数规模壮大,但中医临床思维和中医解决临床问题的能力比较弱。传承博士后制度创新了人才培养制度、理念和模式。就地培养、跟师学习,由一个流动站在全国范围内异地培养博士后,是院校教育和师承教育的高层次结合,有利于传承名老中医的特色理论和临床经验,培养具有较高临床实践能力和理论创新水平的高层次中医药临床领军人才。

论坛上,传承合作导师代表、上海中医药大学教授施杞表示,传承博士后与一般的博士后合作研究有着根本区别。学生要在传承上下工夫,对老师的学术问题、学术经验、学术成就以及学术特点、创新点进行总结、分析。老师在指导学生完成合作研究任务的同时,也能使自己的学术观点更加明确、学术经验更加系统、学术成绩更加突出,自身得到提高。

“中医药传承博士后项目是博士后制度在中医药高层次人才培养方式上的创新。”人社部留学人员和专家服务中心党委书记、副主任,中国博士后科学基金会副秘书长邱春雷说。

全国首批中医药传承博士后项目由国家中医药管理局主管,中国中医科学院博士后科研流动站具体实施。经过4年的跟师学习,共有102名传承博士后完成在站研究工作,申请国家级及省部级科研课题210余项,在国内核心期刊发表论文510余篇,SCI文章40余篇,作为主编或参与(前三名)编写中医药传承学术着作120余部。其中,28名传承博士后的出站报告在出站考核中被评为优秀。论坛现场为优秀传承成果奖获得者颁发证书。

论坛上,传承博士后导师、全国名中医翁维良、陈宝贵作专题报告。当天还召开了传承博士后培养模式座谈会、传承成果汇报交流会。13位传承博士后代表以导师学术思想和临证经验为核心内容进行了交流。

中国中医科学院党委书记王炼出席论坛。论坛由全国博士后管委会办公室、国家中医药管理局主办,中国中医科学院承办。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1675561, encodeId=5d5216e556186, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sat Aug 04 23:31:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877800, encodeId=289918e7800fa, content=<a href='/topic/show?id=bb7e3643897' target=_blank style='color:#2F92EE;'>#博士后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36438, encryptionId=bb7e3643897, topicName=博士后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Thu Jun 07 05:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409235, encodeId=d04914092355a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Dec 24 01:31:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271497, encodeId=4a8d2e14971d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Dec 22 10:40:49 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2018-08-04 lishizhe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1675561, encodeId=5d5216e556186, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sat Aug 04 23:31:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877800, encodeId=289918e7800fa, content=<a href='/topic/show?id=bb7e3643897' target=_blank style='color:#2F92EE;'>#博士后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36438, encryptionId=bb7e3643897, topicName=博士后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Thu Jun 07 05:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409235, encodeId=d04914092355a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Dec 24 01:31:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271497, encodeId=4a8d2e14971d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Dec 22 10:40:49 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1675561, encodeId=5d5216e556186, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sat Aug 04 23:31:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877800, encodeId=289918e7800fa, content=<a href='/topic/show?id=bb7e3643897' target=_blank style='color:#2F92EE;'>#博士后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36438, encryptionId=bb7e3643897, topicName=博士后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Thu Jun 07 05:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409235, encodeId=d04914092355a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Dec 24 01:31:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271497, encodeId=4a8d2e14971d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Dec 22 10:40:49 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2017-12-24 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1675561, encodeId=5d5216e556186, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sat Aug 04 23:31:00 CST 2018, time=2018-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877800, encodeId=289918e7800fa, content=<a href='/topic/show?id=bb7e3643897' target=_blank style='color:#2F92EE;'>#博士后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36438, encryptionId=bb7e3643897, topicName=博士后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e729101, createdName=huanbaofeng, createdTime=Thu Jun 07 05:31:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409235, encodeId=d04914092355a, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Dec 24 01:31:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271497, encodeId=4a8d2e14971d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Dec 22 10:40:49 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2017-12-22 神功盖世

    学习

    0